Abingdon Health USA Inc. Opening of New Madison Facility with Ribbon Cutting Ceremony
Abingdon Health USA Inc., a subsidiary of UK-based global leader in rapid diagnostics Abingdon Health plc, celebrated its recent opening with a ribbon cutting ceremony on April 9 2025 at its new location in the MGE Innovation Center at University Research Park in Madison, WI.
Abingdon Health USA’s new laboratory and commercial office represents a significant milestone in the company's global expansion strategy, driven by growing demand from U.S. customers.
Madison Mayor, Satya Rhodes-Conway, who attended the ribbon cutting ceremony, commented:
“On behalf of the City, I’d like to welcome Abingdon Health USA to Madison. Abingdon Health’s decision to locate their new US operations in Madison, Wisconsin, underscores the strength of our nationally-renowned biohealth industry as well as our commitment to innovation and business. It’s particularly exciting that Abingdon Health’s work on diagnostics has the potential to help make affordable and quality healthcare accessible to much wider audiences. We look forward to supporting their growth and success as they become part of our rapidly expanding ecosystem for biohealth and precision medicine.”
Chris Yates, President of Abingdon Health USA Inc. and Abingdon Health plc Chief Commercial Officer, commented:
"With an increasing share of Abingdon Health's global business coming from the U.S., we are excited to expand our footprint in Madison to be closer to our U.S. customers and start to serve this significant, growing market from our US operation.”
"Ultimately, the choice to establish our U.S. headquarters in Madison was an easy one. The region offers a globally renowned biohealth industry with several leading healthcare companies, a world-class university excelling in research and entrepreneurship, the local significance of the dairy industry, a supportive ecosystem for newly-arrived companies, and a highly skilled workforce where employees are passionate and want to work hard."
Max Duckworth, Director of Abingdon Health USA Inc., commented:
“We’d like to express our ongoing gratitude to the many local organizations and institutions that supported our decision-making process, including the City of Madison, the Madison Chamber of Commerce, BioForward, the University of Wisconsin-Madison and UW Health, University Research Park, Findorff, Madison Regional Economic Partnership, the Tech Council, Wisconsin Economic Development Corporation, and others.”
"Abingdon Health USA is excited to open up in Madison and contribute to Wisconsin’s thriving biohealth industry through our complementary expertise in point-of-care diagnostics and regulatory services for healthcare companies large and small.”
Watch the WMTV 15 News item on the ribbon cutting by clicking the image below:
About Abingdon Health
Abingdon Health plc is a leading med-tech contract service provider offering its services to an international customer base. It is public company quoted on the London Stock Exchange (AIM: ABDX).
The Group's CDMO division offers lateral flow product development, regulatory support, technology transfer and manufacturing services for customers looking to develop new assays or transfer existing laboratory-based assays to a lateral flow format. Abingdon Health's CDMO division has the internal capabilities to take lateral flow projects, in areas such as infectious disease and clinical testing, including companion diagnostics, animal health and environmental testing, from initial concept through to routine and large-scale manufacturing; from "idea to commercial success".
Abingdon Health's regulatory services companies, Compliance Solutions (Life Sciences) and IVDeology provide a broad range of regulatory services to the in vitro diagnostic and wider medical device industry, to support customers in bringing products to market across a range of territories including the USA, EU and the UK. Our consultancy services range from design, implementation and maintenance of quality management systems, preparation of technical files for regulatory approvals, part-time and interim management support, auditing both internally (e.g. Quality Management Systems) and externally (e.g. critical suppliers), management reviews and presentations, training and mentoring.
Abingdon Simply TestTM range of self-tests are marketed via an e-commerce platform that offers a range of self-tests to empowers consumers to manage their own health and wellbeing. The Abingdon Simply TestTM e-commerce site offers consumers a range of information to support them in making informed decisions on the tests available. In addition, the site provides Abingdon's contract services customers with a potential route to market for self-tests. The Abingdon Simply Test range and other selected self-test products, such as the saliva pregnancy test, SalistickTM, is also sold through international distributors and through other channels in the UK and Ireland, such as pharmacy chains.
Founded in 2008, Abingdon Health is headquartered in York, England with CDMO facilities in both York, UK and Madison, Wisconsin, USA.
For more information visit: www.abingdonhealth.com
